Companies › OABI
OMNIAB INC (OABI)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001846253 · EDGAR filings · Updated 2026-07-13
OMNIAB INC (OABI) has reported institutional ownership of 38.6%, with 129 institutional managers holding positions valued at $87.7M per the latest 13F reporting period. SEC filings include an active non-reliance notice on previously issued financial statements (8-K Item 4.02), notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Latest updates
- 2026-07-13 — Initial insider ownership filed (Form 3)
- 2026-07-13 — Current report (8-K) filed
- 2026-06-18 — Insider transaction reported (Form 4)
- 2026-06-18 — Insider transaction reported (Form 4)
- 2026-06-18 — Insider transaction reported (Form 4)
- 2026-06-18 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, OMNIAB INC has 129 institutional holders and institutional ownership of 38.6%.
Insider activity
Insiders reported 39 transactions (5 buys, 13 sells) across 7 reporting insiders, with a net reported value of −$45.9K.
Data flags from SEC filings
Related companies
KORU MEDICAL SYSTEMS INC (KRMD) · FATE THERAPEUTICS INC (FATE) · PRECISION BIOSCIENCES INC (DTIL) · TILRAY BRANDS INC (TLRY) · SIGHT SCIENCES INC (SGHT) · TRISALUS LIFE SCIENCES (TLSI)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-13.